Please login to the form below

Not currently logged in
Email:
Password:

Teva Generics Europe appoints president and CEO

Promotes former UK general manager Richard Daniell

Teva Richard DaniellTeva has appointed Richard Daniell as president and chief executive officer of Teva Generics Europe, following Dipankar Bhattacharjee's promotion to a global role.

Daniell has over 25 years of experience working at Teva and served as the company's chief integration officer, leading the integration programme to bring Actavis and Teva together.

Prior to this, he was chief operating officer, growth markets region and served as general manager of Teva UK from 2011 to 2015.

Bhattacharjee, president and chief executive of global generic medicines said: “Richard has shown visionary leadership, has built high-performing teams across the company and has an impressive record in driving commercial success.”

21st December 2016

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Four Health Communications

Formerly known as Packer Forbes Communications, Four Health Communications is an award-winning, integrated healthcare communications agency for pharma, biotech, NGOs...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics